Genomic and transcriptomic data analyses highlight KPNB1 and MYL4 as novel risk genes for congenital heart disease
View ORCID ProfileMartin Broberg, Minna Ampuja, Samuel Jones, Tiina Ojala, Otto Rahkonen, Riikka Kivelä, View ORCID ProfileJames Priest, FinnGen, Hanna M. Ollila, View ORCID ProfileEmmi Helle
doi: https://doi.org/10.1101/2022.01.07.22268881
Martin Broberg
1Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
Minna Ampuja
1Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Samuel Jones
2Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
Tiina Ojala
3New Children’s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland
Otto Rahkonen
3New Children’s Hospital, Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland
Riikka Kivelä
1Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
4Wihuri Research Institute, Helsinki, Finland
5Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
James Priest
6Stanford University School of Medicine, Stanford, CA, USA
Hanna M. Ollila
2Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
7Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA., USA and Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA
8Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Emmi Helle
1Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
2Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
Posted January 08, 2022.
Genomic and transcriptomic data analyses highlight KPNB1 and MYL4 as novel risk genes for congenital heart disease
Martin Broberg, Minna Ampuja, Samuel Jones, Tiina Ojala, Otto Rahkonen, Riikka Kivelä, James Priest, FinnGen, Hanna M. Ollila, Emmi Helle
medRxiv 2022.01.07.22268881; doi: https://doi.org/10.1101/2022.01.07.22268881
Genomic and transcriptomic data analyses highlight KPNB1 and MYL4 as novel risk genes for congenital heart disease
Martin Broberg, Minna Ampuja, Samuel Jones, Tiina Ojala, Otto Rahkonen, Riikka Kivelä, James Priest, FinnGen, Hanna M. Ollila, Emmi Helle
medRxiv 2022.01.07.22268881; doi: https://doi.org/10.1101/2022.01.07.22268881
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (676)
- Anesthesia (182)
- Cardiovascular Medicine (2676)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12303)
- Forensic Medicine (10)
- Gastroenterology (768)
- Genetic and Genomic Medicine (4148)
- Geriatric Medicine (389)
- Health Economics (684)
- Health Informatics (2688)
- Health Policy (1009)
- Hematology (365)
- HIV/AIDS (859)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3930)
- Nursing (212)
- Nutrition (584)
- Oncology (2068)
- Ophthalmology (592)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (252)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1128)
- Primary Care Research (461)
- Public and Global Health (6572)
- Radiology and Imaging (1418)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)